Document is current
Any future updates will be listed below
-
Authors
Kurabi, Arwa https://orcid.org/0000-0001-5765-9496
Schaerer, Daniel
Noack, Volker
Bernhardt, Marlen
Pak, Kwang
Alexander, Thomas
Husseman, Jacob
Nguyen, Quyen
Harris, Jeffrey P.
Ryan, Allen F.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (DC000129, DC012495, DC014801, DC000129, DC012495)
VA | Veterans Affairs San Diego Healthcare System (BX001205)
U.S. Department of Veterans Affairs (BX001205)
- License Information
-
More Information
Article History
Received: 26 January 2018
Accepted: 2 July 2018
First Online: 7 August 2018
Competing Interests
: Dr. Ryan and Dr. Harris are co-founders of, shareholders in, and consultants to Otonomy, Inc., which develops slow-release therapeutics for the treatment of various ear disorders. This relationship has been approved by the U.C.S.D. and San Diego V.A. Committees on Conflict of Interest. The company played no role in the research reported here. Dr. Ryan and Dr. Harris declare that no potential competing financial interests exist.
